<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>6242048</identifier>
<setSpec>0300-9041</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Velasco Murillo, V</dc:author>
<dc:author>Correu Azcona, S</dc:author>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:subject>Central America</dc:subject>
<dc:subject>Medroxyprogesterone Acetate--complications</dc:subject>
<dc:subject>Contraceptive Methods--indications</dc:subject>
<dc:subject>Contraceptive Methods--contraindications</dc:subject>
<dc:subject>Injectables--indications</dc:subject>
<dc:subject>Hormones</dc:subject>
<dc:subject>Contraception--complications</dc:subject>
<dc:subject>Contraceptive Agents--indications</dc:subject>
<dc:subject>North America</dc:subject>
<dc:subject>Latin America</dc:subject>
<dc:subject>Contraceptive Agents--contraindications</dc:subject>
<dc:subject>Physiology</dc:subject>
<dc:subject>Norethindrone Acetate--complications</dc:subject>
<dc:subject>Contraceptive Agents, Female--indications</dc:subject>
<dc:subject>Contraceptive Agents--complications</dc:subject>
<dc:subject>Family Planning</dc:subject>
<dc:subject>Injectables--side effects</dc:subject>
<dc:subject>Diseases</dc:subject>
<dc:subject>Norethindrone--contraindications</dc:subject>
<dc:subject>Injectables--contraindications</dc:subject>
<dc:subject>Norethindrone--complications</dc:subject>
<dc:subject>Contraceptive Agents, Progestin--contraindications</dc:subject>
<dc:subject>Norethindrone--indications</dc:subject>
<dc:subject>Injectables--complications</dc:subject>
<dc:subject>Contraceptive Agents, Progestin--side effects</dc:subject>
<dc:subject>Developing Countries</dc:subject>
<dc:subject>Medroxyprogesterone Acetate--indications</dc:subject>
<dc:subject>Metabolic Effects</dc:subject>
<dc:subject>Americas</dc:subject>
<dc:subject>Contraceptive Methods--complications</dc:subject>
<dc:subject>Biology</dc:subject>
<dc:subject>Medroxyprogesterone Acetate--side effects</dc:subject>
<dc:subject>Norethindrone Acetate--contraindications</dc:subject>
<dc:subject>Contraceptive Agents--side effects</dc:subject>
<dc:subject>Contraception--contraindications</dc:subject>
<dc:subject>Norethindrone--side effects</dc:subject>
<dc:subject>Contraceptive Agents, Female--contraindications</dc:subject>
<dc:subject>Norethindrone Acetate--side effects</dc:subject>
<dc:subject>Norethindrone Acetate--indications</dc:subject>
<dc:subject>Contraceptive Methods--side effects</dc:subject>
<dc:subject>Endocrine System</dc:subject>
<dc:subject>Contraception--side effects</dc:subject>
<dc:subject>Developed Countries</dc:subject>
<dc:subject>Contraception--indications</dc:subject>
<dc:subject>Contraceptive Agents, Female--complications</dc:subject>
<dc:subject>Mexico</dc:subject>
<dc:subject>Contraceptive Agents, Progestin--indications</dc:subject>
<dc:subject>Medroxyprogesterone Acetate--contraindications</dc:subject>
<dc:subject>Contraceptive Agents, Female--side effects</dc:subject>
<dc:subject>Contraceptive Agents, Progestin--complications</dc:subject>
<dc:date>1983 Jul </dc:date>
<dc:title xml:lang="es">Anticoncepción inyectable con progestágenos de depósito.</dc:title>
<dc:title xml:lang="en">[Injectable contraception using depot progestagens].</dc:title>
<dc:publisher>Ginecologia y obstetricia de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
